New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective

JAMA. 1996 Feb 7;275(5):401-3.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / prevention & control
  • Bacterial Vaccines
  • Communicable Disease Control / trends*
  • Drug Design*
  • Drug Industry / trends*
  • Drug Resistance, Microbial* / genetics
  • Drug Resistance, Microbial* / physiology
  • Genes, Bacterial / drug effects
  • Humans
  • Virulence / drug effects

Substances

  • Anti-Bacterial Agents
  • Bacterial Vaccines